BDBM796568 (17E)-16-ethyl-8,12,14-trimethyl- 2,11,12,14-tetrahydro-8H-3,5- ethenotripyrazolo[3,4-f:3'',4''-j:4$#8243;,3$#8243;- n][1,4]oxazacyclopentadecin-13(10H)- one::US20260070924, Example 6

SMILES CCc1nn(C)c2c1/C=C/c1n[nH]c3ccc(cc13)-c1cnn(C)c1OCCN(C)C2=O

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 20 hits for monomerid = 796568   

TargetDimer of Receptor-type tyrosine-protein kinase FLT3 [D835V](Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796568BDBM796568((17E)-16-ethyl-8,12,14-trimethyl- 2,11,12,14-tetra...)
Affinity DataKd:  0.0580nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details US Patent

TargetReceptor-type tyrosine-protein kinase FLT3 [D835V](Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796568BDBM796568((17E)-16-ethyl-8,12,14-trimethyl- 2,11,12,14-tetra...)
Affinity DataKd:  0.0620nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details US Patent

TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796568BDBM796568((17E)-16-ethyl-8,12,14-trimethyl- 2,11,12,14-tetra...)
Affinity DataIC50: 0.0880nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details US Patent

TargetSerine/threonine-protein kinase pim-3(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796568BDBM796568((17E)-16-ethyl-8,12,14-trimethyl- 2,11,12,14-tetra...)
Affinity DataIC50: 0.115nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details US Patent

TargetDual specificity protein kinase CLK1(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796568BDBM796568((17E)-16-ethyl-8,12,14-trimethyl- 2,11,12,14-tetra...)
Affinity DataIC50: 0.134nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details US Patent

TargetDual specificity protein kinase CLK2(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796568BDBM796568((17E)-16-ethyl-8,12,14-trimethyl- 2,11,12,14-tetra...)
Affinity DataIC50: 0.165nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details US Patent

TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796568BDBM796568((17E)-16-ethyl-8,12,14-trimethyl- 2,11,12,14-tetra...)
Affinity DataKd:  0.180nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details US Patent

TargetDimer of Receptor-type tyrosine-protein kinase FLT3 [F691L](Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796568BDBM796568((17E)-16-ethyl-8,12,14-trimethyl- 2,11,12,14-tetra...)
Affinity DataKd:  0.230nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details US Patent

TargetDimer of Receptor-type tyrosine-protein kinase FLT3(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796568BDBM796568((17E)-16-ethyl-8,12,14-trimethyl- 2,11,12,14-tetra...)
Affinity DataIC50: 0.348nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details US Patent

TargetDual specificity protein kinase CLK4(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796568BDBM796568((17E)-16-ethyl-8,12,14-trimethyl- 2,11,12,14-tetra...)
Affinity DataIC50: 0.446nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details US Patent

TargetReceptor-type tyrosine-protein kinase FLT3 [R834Q](Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796568BDBM796568((17E)-16-ethyl-8,12,14-trimethyl- 2,11,12,14-tetra...)
Affinity DataIC50: 0.890nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details US Patent

TargetReceptor-type tyrosine-protein kinase FLT3 [N841I](Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796568BDBM796568((17E)-16-ethyl-8,12,14-trimethyl- 2,11,12,14-tetra...)
Affinity DataIC50: 2.20nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796568BDBM796568((17E)-16-ethyl-8,12,14-trimethyl- 2,11,12,14-tetra...)
Affinity DataIC50: 2.65nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details US Patent

TargetReceptor-type tyrosine-protein kinase FLT3 [D835Y](Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796568BDBM796568((17E)-16-ethyl-8,12,14-trimethyl- 2,11,12,14-tetra...)
Affinity DataKd:  4.10nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details US Patent

TargetSerine/threonine-protein kinase pim-2(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796568BDBM796568((17E)-16-ethyl-8,12,14-trimethyl- 2,11,12,14-tetra...)
Affinity DataIC50: 5.68nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details US Patent

TargetDual specificity protein kinase CLK3(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796568BDBM796568((17E)-16-ethyl-8,12,14-trimethyl- 2,11,12,14-tetra...)
Affinity DataIC50: 5.87nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details US Patent

TargetDimer of Receptor-type tyrosine-protein kinase FLT3(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796568BDBM796568((17E)-16-ethyl-8,12,14-trimethyl- 2,11,12,14-tetra...)
Affinity DataKd:  6.30nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details US Patent

TargetDimer of Receptor-type tyrosine-protein kinase FLT3(Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796568BDBM796568((17E)-16-ethyl-8,12,14-trimethyl- 2,11,12,14-tetra...)
Affinity DataIC50: 9.10nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details US Patent

TargetReceptor-type tyrosine-protein kinase FLT3 [K663Q](Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796568BDBM796568((17E)-16-ethyl-8,12,14-trimethyl- 2,11,12,14-tetra...)
Affinity DataIC50: 16nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details US Patent

TargetReceptor-type tyrosine-protein kinase FLT3 [D835H](Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 796568BDBM796568((17E)-16-ethyl-8,12,14-trimethyl- 2,11,12,14-tetra...)
Affinity DataKd:  67nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/23/2026
Entry Details US Patent